New developments in the induction and antiviral effectors of type I interferon
about
IFITM proteins restrict viral membrane hemifusion.IFITM proteins restrict antibody-dependent enhancement of dengue virus infectionEvolutionary conflicts between viruses and restriction factors shape immunitySystems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivityOpposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plagueTRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A proteinSolute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of HepatocytesEmerging therapies for systemic lupus erythematosus--focus on targeting interferon-alphaHuman genome-wide RNAi screen identifies an essential role for inositol pyrophosphates in Type-I interferon responseThe interferon-inducible gene viperin restricts West Nile virus pathogenesisInterferons and their receptors in birds: a comparison of gene structure, phylogenetic analysis, and cross modulationTwo-stepping through time: mammals and virusesProtein Interferon-Stimulated Gene 15 Conjugation Delays but Does Not Overcome Coronavirus Proliferation in a Model of Fulminant HepatitisA moderate increase in ambient temperature modulates the Atlantic cod (Gadus morhua) spleen transcriptome response to intraperitoneal viral mimic injectionResistance to simian immunodeficiency virus low dose rectal challenge is associated with higher constitutive TRIM5α expression in PBMCHerpes Simplex Virus and Interferon Signaling Induce Novel Autophagic Clusters in Sensory NeuronsInnate nuclear sensor IFI16 translocates into the cytoplasm during the early stage of in vitro human cytomegalovirus infection and is entrapped in the egressing virions during the late stage.The interferon-induced gene Ifi27l2a is active in lung macrophages and lymphocytes after influenza A infection but deletion of Ifi27l2a in mice does not increase susceptibility to infection.2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivoHow Ebola virus counters the interferon system.The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells.Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms.Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production.IFN-ε is constitutively expressed by cells of the reproductive tract and is inefficiently secreted by fibroblasts and cell lines.A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replicationRIG-I-dependent antiviral immunity is effective against an RNA virus encoding a potent suppressor of RNAi.Six host-range restricted poxviruses from three genera induce distinct gene expression profiles in an in vivo mouse modelIfih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity.Melanoma differentiation-associated gene 5 is critical for protection against Theiler's virus-induced demyelinating disease.Permissiveness of human hepatoma cell lines for HCV infection.S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virusType I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicityIFN type I and type II independent enhancement of B cell TLR7 expression by natural killer cells.Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectivesA FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses.Ubiquitination in the antiviral immune responseInduction of the type I interferon response in neurological forms of Gaucher diseaseUBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS.Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS
P2860
Q21558779-4E5EB055-1D2A-4814-96C1-42CF0B1B04B3Q24311739-5F9DEC8E-7E69-4498-A59B-5A447A7331C3Q27022032-3A0D058A-35B1-44B5-A920-9CDAFAE77226Q27335125-92A91ABA-8577-4DF9-A57C-0D03C5340A66Q27343051-A14E54ED-3586-47B8-8D0B-7FCE845922F4Q27468803-84F7DFF0-2B3B-41CB-807B-78AE2E0C65D0Q27928046-8A72223B-6B29-42EC-BE27-048271A2D998Q28265144-CDADD714-EFE1-4169-A4B9-82F1BEB29346Q28540195-9AA7FCEA-0D48-4D33-8F3B-697114CEC70BQ28594932-4FF2133F-398C-42F0-85C5-A9BFE28877F7Q28649915-DACCEF10-99E9-4D27-B88F-78DC3DF3DA34Q28709092-A92FE3C6-0B13-4893-958C-3DDE7351130BQ30049307-42498473-10E3-45EF-BA9A-4FBB988A5AFDQ30559646-7E593483-D4B3-4A39-BF19-4E62F58C3CA1Q30579576-FD1F0E3F-446B-4574-82A0-DE7E67C38468Q30744548-123923A7-FA12-4C02-AB2C-E4D2992C53A3Q33743805-AAA447D3-F38E-4F1C-ACF7-39E5249C082EQ34128745-9DAB4E3E-5CC2-42F4-B680-73E9A3DEFABFQ34270459-1EE41CBB-F747-470F-9E21-E109FB909EE2Q34298213-3CC924B9-CACA-4F82-AAA4-1FBE1C4E43CDQ34388476-AF3498F2-1209-4E78-9291-09BD0256D2C5Q34616709-C00B22B9-7CBC-480A-8B70-6CA138657B7EQ34627384-417EEE55-D5DB-4DEF-8F50-4F0FBD799C65Q34819672-DEBD7C99-A95B-4609-93DD-959F9F39AA5AQ34949247-2C53B501-5CA7-4A71-B3BD-7AFDA6BA2C3AQ35487689-02CBB55B-F7DC-4824-B0B3-651CEF420867Q35588762-D83923AE-480C-43E6-9341-43B50F16467BQ35685675-CFE8992E-5E77-46E9-8679-8BA5B9CEE657Q35685720-70FB5672-3B8E-42D7-A41A-D8D2F25D49A4Q35689719-2987AAD0-7503-4295-9808-CE15FAEC5215Q35866290-E05D053B-087D-4369-8584-A4C68CE3345CQ36003903-CBB29EB8-6870-4718-AA8D-BAC0318D3135Q36016455-5B43FBFD-C6D0-4CB8-912E-FCF9B45EF1DEQ36232213-B6119002-FCED-407C-8F59-BA88D016CE82Q36422111-6BFA50F2-969F-4CB4-8D8A-FB0556465E9BQ36567669-095678B2-E4B2-4B34-8DF7-7282EABDA8CEQ36640618-58D1C760-B7A7-4866-8601-8BECFC0A0F06Q36898538-AA254954-EEB3-4DBF-9A23-C361BB68C7E4Q36998981-9DB17F2B-E37F-45ED-BE19-5BBCEB8D11F7Q37174376-85E3443C-6DAE-4005-8938-487C8AB2D025
P2860
New developments in the induction and antiviral effectors of type I interferon
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
New developments in the induction and antiviral effectors of type I interferon
@en
New developments in the induction and antiviral effectors of type I interferon.
@nl
type
label
New developments in the induction and antiviral effectors of type I interferon
@en
New developments in the induction and antiviral effectors of type I interferon.
@nl
prefLabel
New developments in the induction and antiviral effectors of type I interferon
@en
New developments in the induction and antiviral effectors of type I interferon.
@nl
P2860
P1476
New developments in the induction and antiviral effectors of type I interferon
@en
P2093
David Jesse Sanchez
Su-Yang Liu
P2860
P356
10.1016/J.COI.2010.11.003
P577
2010-11-29T00:00:00Z